US COPD Coalition

Month: March 2020

Mar
30

Pulmonary Rehab During Pandemic Guidance Document Available

One of the many disruptions caused by the COVID-19 pandemic is the closure of pulmonary rehabilitation (PR) programs throughout the country. Fortunately, there are resources available to help patients maintain a semblance of normalcy during this crisis. A guidance document released by the American Thoracic Society offers suggestions on filling the pulmonary rehab void while … Read more

Mar
27

AARC Launches Virtual Lobby Campaign Ahead of Hill Day

The American Association for Respiratory Care (AARC) has launched its “virtual lobby campaign” to advocate for two issues that are very important to the U.S. COPD Coalition and patients with chronic lung disease. The AARC is asking members of the U.S. House of Representatives to co-sponsor the Better Respiration Through Expanding Access to Tele-Health Act (the BREATHE … Read more

Mar
24

USCC Seeks Waiver to Allow Increased Access to Respiratory Therapists During Pandemic

The US COPD Coalition (USCC), along with six member organizations, have written to Health & Human Services Secretary Alex Azar and Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma seeking a temporary waiver of certain CMS rules that would allow for greater access to respiratory therapists during the COVID-19 pandemic. Specifically, the waiver … Read more

Mar
23

Alpha-1 Foundation Asks CMS to Allow Home Infusions

The Alpha-1 Foundation has sent letters to the United States Senate and House of Representatives requesting that intravenous infusions of alpha-1 antitrypsin augmentation therapy be released from the prohibition of home infusions and that CMS covers both the medication and its administration at home as it currently does for administration in healthcare facilities. Under current … Read more

Mar
18

NIH Director Stresses the Importance of Social Distancing and Prevention to “Flatten the Curve”

Dr. Francis Collins, Director of the National Institutes of Health (NIH) was interviewed recently by The Atlantic, and he warned of the exponential growth in the number of coronavirus cases the United States can expect to see in the coming days and weeks if “draconian measures” are not taken to prevent the spread of the virus. … Read more

Mar
16

NIH Begins Clinical Trial of Experimental COVID-19 Vaccine

The National Institutes of Health has announced that a Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is funding … Read more

Mar
3

Coronavirus 2019 – Prevention & Treatment

The following is re-printed from the Centers for Disease Control & Prevention’s  Coronavirus Disease 2019 website: Prevention There is currently no vaccine to prevent coronavirus disease 2019 (COVID-19). The best way to prevent illness is to avoid being exposed to this virus. However, as a reminder, CDC always recommends everyday preventive actions to help prevent the spread … Read more